Cellular immune endophenotypes separating early and late-onset myasthenia gravis
JCI Insight · 2026
DOI: 10.1172/jci.insight.199679 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2026. Verfasst von Jakob Theorell und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Myasthenia Gravis, Endophenotypes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, European joint programme for rare diseases, Region Stockholm.
Abstract (Originalsprache)
The 2 main subgroups of autoimmune myasthenia gravis, a neuromuscular junction disorder associated with muscle weakness, are early- and late-onset forms, defined by onset before or after 50 years of age. Both carry acetylcholine-receptor autoantibodies but differ in sex ratios, genetics, and occurrence of disease-specific thymus inflammation. To distinguish the 2 forms by cellular immune phenotyping, we applied multimodal techniques, including deep spectral cytometric phenotyping and single-cell sequencing. Analysis of 2 independent cohorts identified immunological differences driven by 3 main lymphocyte populations. Lower frequencies of mucosa-associated invariant T cells and naive CD8 + T cells were observed in late-onset myasthenia, suggesting enhanced immune senescence. A highly differentiated, canonical NK cell population was reduced in early-onset myasthenia and negatively correlated with the degree of thymic hyperplasia. Using only the frequency of these 3 populations, correct myasthenia subgroup assignment could be predicted with 90% accuracy. These distinct immunocellular endophenotypes for early- and late-onset disease suggest differences in immunopathogenic processes. Along with demographic factors and other disease subgroup–specific features, the frequency of the identified cell subpopulations may improve clinical classification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
- Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
- Department of Clinical Neuroscience, Karolinska Institutet, and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
- Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
- Department of Neuroscience and Psychology, University of Florence, Florence, Italy.
- Centre for Human Genetics, and.
Förderung
- Wellcome Trust
- European joint programme for rare diseases
- Region Stockholm
- Swedish Research Council
- Kogod Centre on Aging, Medical Research Council
- Wellcome Trust Fellowship
Zitieren
APA
Theorell, J., Ruffin, N., Fower, A., Sorini, C., Ambrose, P., Damato, V., Handunnetthi, L., Leite, I., Irani, S. R., Brauner, S., Handel, A. E., & Piehl, F. (2026). Cellular immune endophenotypes separating early and late-onset myasthenia gravis. JCI Insight. https://doi.org/10.1172/jci.insight.199679
Vancouver
Theorell J, Ruffin N, Fower A, Sorini C, Ambrose P, Damato V, et al. Cellular immune endophenotypes separating early and late-onset myasthenia gravis. JCI Insight. 2026. doi:10.1172/jci.insight.199679
BibTeX
@article{Theorell2026,
author = {Theorell, Jakob and Ruffin, Nicolas and Fower, Andrew and Sorini, Chiara and Ambrose, Philip and Damato, Valentina and Handunnetthi, Lahiru and Leite, Isabel and Irani, Sarosh R and Brauner, Susanna and Handel, Adam E and Piehl, Fredrik},
title = {Cellular immune endophenotypes separating early and late-onset myasthenia gravis},
journal = {JCI Insight},
year = {2026},
doi = {10.1172/jci.insight.199679}
}
EUVIMED